New 'promising medicines' fund may aid commercialization of high price drugs with weak evidence on clinical benefits
A new fund to fast-track patient access to potentially valuable new medicines may incentivize the pharmaceutical industry to develop high priced drugs for rare diseases with weak evidence on clinical benefits.
Aug 25, 2023
0
1